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Naturally occurring variants of the enzyme choris-
mate mutase are known to exist that exhibit diversity in
enzyme structure, regulatory properties, and associa-
tion with other proteins. Chorismate mutase was not
annotated in the initial genome sequence of Mycobacte-
rium tuberculosis (Mtb) because of low sequence simi-
larity between known chorismate mutases. Recombi-
nant protein coded by open reading frame Rv1885c of
Mtb exhibited chorismate mutase activity in vitro. Bio-
chemical and biophysical characterization of the recom-
binant protein suggests its resemblance to the AroQ
class of chorismate mutases, prototype examples of
which include the Escherichia coli and yeast chorismate
mutases. We also demonstrate that unlike the corre-
sponding proteins of E. coli, Mtb chorismate mutase
does not have any associated prephenate dehydratase
or dehydrogenase activity, indicating its monofunc-
tional nature. The Rv1885c-encoded chorismate mutase
showed allosteric regulation by pathway-specific as well
as cross-pathway-specific ligands, as evident from pro-
teolytic cleavage protection and enzyme assays. The
predicted N-terminal signal sequence ofMtb chorismate
mutase was capable of functioning as one in E. coli,
suggesting that Mtb chorismate mutase belongs to the
AroQ class of chorismate mutases. It was evident that
Rv1885c may not be the only enzyme with chorismate
mutase enzyme function within Mtb, based on our ob-
servation of the presence of chorismate mutase activity
displayed by another hypothetical protein coded by
open reading frame Rv0948c, a novel instance of the
existence of two monofunctional chorismate mutases
ever reported in any pathogenic bacterium.
Mycobacterium tuberculosis (Mtb)1 has developed ingenious
mechanisms to survive inside the hostile environment pre-
sented by the host and to acquire essential nutrients from this
adverse environment (1–3). The emergence of drug-resistant
strains and synergy with the AIDS virus has further aggra-
vated the disease scenario (4–6). For the development of new
therapeutic intervention strategies, there is a need for identi-
fication of novel targets that are not only unique to Mtb but
blocking of which would either prove lethal to the bacterium or
render it extremely susceptible to the host immune response.
In this context, understanding the mechanism of action of the
aromatic amino acid pathway enzymes of Mtb assumes the
utmost importance because most of the corresponding genes
have been proven essential for the bacterium and have no
human or mammalian counterpart (7, 8). Moreover, amino acid
auxotrophs of Mtb do not survive or multiply in macrophages
(9, 10), suggesting that these amino acids are not available
within the compartment of the macrophage in which the bac-
teria reside.
Chorismic acid is the last common precursor in the aromatic
amino acid biosynthesis pathway and is a substrate for multi-
ple enzymes (11, 12). Hence it has always been of interest to
explore how a microbe partitions chorismate into diverse met-
abolic pathways. Various enzymes that utilize chorismate as a
substrate include chorismate mutase (CM), anthranilate syn-
thase, isochorismate synthase, and p-amino benzoate synthase
(13). Chorismate mutase is a key regulatory enzyme of the
shikimate pathway that catalyzes the Claisen rearrangement
of chorismate to prephenate (Fig. 1), a committed step in L-Phe
and L-Tyr biosynthesis. Besides being a rare example of an
enzyme that catalyzes a pericyclic rearrangement reaction,
chorismate mutase has also gathered attention due to the
presence of completely different protein folds and ligand bind-
ing pockets in different organisms. Members of the AroQ class
of chorismate mutases are all helix-bundle proteins, whereas
members of the AroH class of chorismate mutases possess a
trimeric pseudo-/-barrel structure (14). The chorismate mu-
tases of yeast and E. coli belong to the AroQ class of chorismate
mutases (15–21) and are allosterically regulated by aromatic
amino acids. The monofunctional chorismate mutase of Bacil-
lus subtilis falls under the AroH class and is a feedback insen-
sitive enzyme (22, 23).
The low similarity at the amino acid sequence level among
known chorismate mutases makes the enzyme one of the finest
examples of convergent evolution of enzyme reaction mecha-
nisms (24). However, this low sequence similarity also accounts
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for the lack of confidence in the annotation of the enzyme in
genome annotation projects. On the other hand, the uniqueness
of the enzyme also makes it an attractive target for herbicides
and antibacterial compounds (25).
Chorismate mutase was not annotated in the initial ge-
nome sequence of Mtb. However, the recent Cluster of Or-
thologous groups (NCBI) annotation of the Mtb genome sug-
gests that chorismate mutase activity can be attributed to
two ORFs, Rv1885c and Rv0948c (www.ncbi.nlm.nih.gov/
COG/). The ORF Rv1885c has been annotated in the Tuber-
cuList web server (genolist.pasteur.fr/TubercuList/), Insti-
tute Pasteur, as a conserved hypothetical protein with some
similarity to the monofunctional chorismate mutases of Er-
winia herbicola (28.6% identity in a 133-aa overlap). Rv0948c
has also been annotated as a conserved hypothetical protein,
equivalent to a conserved hypothetical protein (105 aa) from
M. leprae (NP_301237.1 NC_002677) that is also similar to
the N terminus of some chorismate mutase/prephenate dehy-
dratase enzymes.
We intended to study whether these two hypothetical pro-
teins indeed show in vitro chorismate mutase activity and, if
they do, how they are related to the two known classes of
chorismate mutases (AroQ and AroH). Our approach involved
expressing the Mtb ORFs Rv1885c and Rv0948c in E. coli and
determining the biochemical and biophysical properties of the
encoded proteins. Whereas more extensive studies were carried
out with the protein coded by ORF Rv1885c, we were also able
to demonstrate that Rv0948 also possesses chorismate mutase
activity, although with a reduced turnover. Kinetic and regu-
latory studies of rRv1885c indicate several unique properties of
the enzyme that include feedback regulation by pathway-spe-
cific as well as cross-pathway-specific ligands in the same man-
ner. We have also used a gene fusion approach for functional
characterization of the predicted N-terminal signal sequence of
Mtb chorismate mutase. Our study provides sufficient evidence
to conclusively place the protein coded by ORF Rv1885c ofMtb
in the AroQ class of periplasmic chorismate mutases.
EXPERIMENTAL PROCEDURES
Bacterial Strains/Plasmids—All bacterial strains used in this study
are described in Table I. The plasmid vectors (with their sources) and the
recombinant plasmids constructed are also described in the same table.
Integrity of all the plasmid clones was confirmed by DNA sequencing.
Cloning, Overexpression, and Purification of Recombinant Proteins
in E. coli—The Mtb ORFs Rv1885c and Rv0948c were amplified from
Mtb H37Rv genomic DNA using primer pairs with specific restriction
enzyme sites (Rv1885c, ATCATATGTTGCTTACCCGTCCACGTGA
(forward) and ATCTCGAGGGCCGGCGGTAGG (reverse); Rv0948c,
AATCATATGAGACCAGAACCCCCACATCACGA (forward) and ATA-
AAGCTTGTGACCGAGGCGGCCCCT (reverse)). The PCR products
were cloned into the corresponding sites of pET23a expression vector
(Novagen). In this way, plasmids pETCM1 and pETCM2 capable of
encoding C-terminal His6-tagged versions of the two putative Mtb cho-
rismate mutases were generated (Table I).
E. coli BL21(DE3) cells transformed with pETCM1 and pETCM2
were grown in 1 liter of LB medium supplemented with 100 g/ml
ampicillin and 10% glycerol. Isopropyl 1-thio--D-galactopyranoside
was added to the mid-log phase culture at a final concentration of 0.1
mM. The cells were kept in an incubator shaker for another 5 h at
27 °C/150 rpm to allow protein expression. A low temperature was used
to allow the protein to enter the soluble phase. After induction, the cells
were harvested by centrifugation and resuspended in 20 ml of lysis
buffer (10 mM Tris-HCl, 100 mM NaCl, and 10% glycerol, pH 7.5) with
0.1 mM phenylmethylsulfonyl fluoride and disrupted using a sonicator.
After another round of centrifugation for 10 min at 10,000  g, the
supernatant was applied to a Talon cobalt affinity resin (Clontech).
Affinity Chromatography—The supernatant was allowed to bind to
Talon resin (Clontech) packed in a polypropylene column. The recom-
binant protein was purified to near homogeneity after washing the
column with 5 bed volumes of lysis buffer containing 30 mM imidazole
and elution with 250 mM imidazole. The eluates were analyzed by
SDS-PAGE and dialyzed against Tris buffer to remove salts and imid-
azole. The purity of the enzyme was checked by SDS-PAGE followed by
Coomassie Blue staining.
Enzyme Assays and Kinetic Studies—Chorismate mutase activity
assays were carried out as described by Davidson and Hudson (26), with
a few modifications. This assay is based on enzymatic conversion of
chorismate to prephenate, which is terminated by the addition of HCl.
Prephenate can be further converted to phenylpyruvate under acidic
conditions that can be measured spectrophotometrically at an alkaline
pH (27). Reaction volumes of 100 l contained 10 mM Tris-HCl, pH 7.5,
chorismic acid (0.5–5 mM), and, optionally, tyrosine, phenylalanine, or
tryptophan (50 M to 3 mM). The pH of the reaction was maintained by
varying the ionic strength of the buffer. The reaction was started by
adding 10–200 pmol of the purified protein to the pre-warmed choris-
mate solution (at 30 °C), and it was stopped by the addition of 10 l of
1.6 N HCl. After a second incubation of the mixture at 37 °C for 15 min,
890 l of 1.58 N NaOH was added, and the absorbance was recorded at
320 nm. To exclude the absorbance caused by the uncatalyzed arrange-
ment of chorismate, blanks of increasing chorismate concentrations
without enzyme were prepared, and their absorbance was also re-
corded. These readings were then subtracted from the absorbance
measured for enzyme activities at different concentrations of the
substrate.
For determination of the optimum enzyme and substrate concentra-
tions, 10–800 pmol of enzyme and 0.5–3 mM chorismic acid were used.
Buffers of different pH values (CPB, pH 4; CPB, pH 4.5; MES, pH 6;
HEPES, pH 7; Tris-HCl, pH 7.5; Tris-HCl, pH 8) were used to deter-
mine the optimum pH for enzyme activity. Chorismate mutase activity
was also assessed at different temperatures (15 °C to 80 °C). One unit
of enzyme was defined as the amount of enzyme required to form 1 mol
product/min at 37 °C.
Prephenate dehydratase and prephenate dehydrogenase assays were
carried out as previously described (26, 28).
Phe, Tyr, and Trp Feedback Inhibition Assays—Allosteric regulation
of chorismate mutase activity by L-Phe, L-Tyr, and L-Trp was measured
at 100–800 M concentrations of the effectors.
Western Blot—Western blot with the cytosolic and periplasmic frac-
tions of E. coli BL21 cells expressingMtb chorismate mutase (Rv1885c)
was carried out with monoclonal anti-His antibody using the manufac-
turer’s instructions (Santa Cruz Biotechnology). The E. coli periplasmic
fraction was isolated using a modified osmotic shock procedure de-
scribed by Qiagen Inc.
Limited Proteolysis—To study the effects of various ligands on en-
zyme stability, integrity, and accessibility of active sites, limited prote-
olysis ofMtb chorismate mutase was carried out. Trypsin was taken as
the protease of choice. Ten g of recombinant protein (1 g/l concen-
tration) was taken, to which different concentrations of the ligand
(tyrosine, phenylalanine, tryptophan, salicylate) were added. The reac-
tion buffer contained 50 mM Tris, pH 7.5, and 100 mM NaCl. Trypsin
was added at a 1:1000 ratio, and the reaction was incubated at 25 °C for
30 min, following which trypsin was inactivated by the addition of 0.5
mM phenylmethylsulfonyl fluoride. The reaction was mixed with an
equal volume of 2 Tris-Tricine loading dye and loaded on a 10%
Tris-Tricine gel.
CD Spectrometry—The CD spectrum of the recombinant protein
FIG. 1. Conversion of chorismate to
prephenate proceeds via a chair-like
transition state. This reaction is a rare
example of an enzyme-catalyzed pericy-
clic reaction.
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(Rv1885c) was recorded in a wavelength range of 190–250 nm in steps
of 1 nm, with four accumulations at each step. The spectral baseline
was corrected by subtracting the respective blanks. Ellipticity, repre-
sented in millidegrees, was plotted as a function of wavelength (in nm).
The percentage of helicity for secondary structure determination was
calculated using the K2D software available on-line (www.
embl-heidelberg.de/andrade/k2d/)
Determination of the Quaternary Structure of Mtb Chorismate Mu-
tase—The oligomeric state of recombinant proteins was determined
using analytical size exclusion chromatography using a Superdex 200
(HP 10/30) fast protein liquid chromatography column from Amersham
Biosciences. Chromatography was performed at room temperature with
10 mM Tris, 100 mM NaCl, and 1 mM dithiothoreitol as the running
buffer, the same buffer in which the recombinant protein was eluted. A
standard curve was prepared according to the instruction manual using
the Low Molecular Weight Gel Filtration calibration kit from Amer-
sham Biosciences. The void volume was determined using blue dextran
2000. The elution parameter Kav was calculated as follows: Kav  Ve 
Vo/Vt Vo, where Ve elution volume for the protein, Vo column void
volume, and Vt  total bed volume. Kav was plotted against log Molec-
ular Weight. The protein sample was chromatographed on the gel
filtration column at a concentration of 4 mg/ml in the presence of
dithiothreitol, and the elution volume was recorded.
Construction of an E. coli Strain Lacking Endogenous Alkaline Phos-
phatase Activity—Strain MGPH1 lacking endogenous alkaline phos-
phatase (PhoA) activity was constructed via bacteriophage P1-mediated
transduction in a two-step process. In the first step, a lysate prepared
on strain GJ1902 was used to transduce wild-type E. coli strain
MG1655 to lacZ::Kan, and the transductants were screened for inher-
itance of the linked proC mutation conferring proline auxotrophy. This
transductant was used as a recipient in the second transduction involv-
ing strain AD494 as a donor, and selection was employed for proline
protrophy. Co-inheritance of the linked phoA deletion was assessed by
screening for transductants lacking PhoA activity on low phosphate
plates containing the PhoA chromogenic substrate XP (29).
Characterization of the Putative N-terminal Signal Sequence of Mtb
Chorismate Mutase in the Heterologous Host E. coli—To validate the
prediction that the N terminus of Mtb chorismate mutase comprising
the first 33 amino acids was capable of functioning as a signal sequence,
we appended this sequence to PhoA, a heterologous protein, and studied
its export in E. coli. Using standard methodologies, a chimeric protein
was generated in which the first 33 amino acids of Mtb chorismate
mutase were fused to the E. coli PhoA lacking its natural signal se-
quence of the first 21 amino acids (ssPhoA). Briefly, ssphoA was
PCR-amplified from E. coli genomic DNA using primer pairs ATGTC-
GACACACCAGAAATGCCTGTTCTG and ATCTCGAGAAGCTTTTA-
TTTCAGCCCCAGAGC and cloned into the SalI and XhoI sites of the
pGEMTEasy vector (Promega), generating plasmid pCDF1. The cloned
PCR product was excised using the enzymes SalI and XhoI and cloned
into the corresponding sites of the pETCM1 plasmid abutting the first
33 amino acids of chorimate mutase to the signal sequence-less PhoA.
This construct was designated as pCDF2. In the next step, pCDF2 was
digested with XbaI and HindIII and cloned into the corresponding sites
of plasmid pBAD18 (30), and the resulting construct was designated as
pCDF3. In this configuration, the expression of the gene encoding the
chimeric protein (CM1ssPhoA) is induced by arabinose, and translation
initiating from the initiation codon of CM would terminate at the stop
codon of ssphoA. A chimeric protein is thereby produced with the first
33 amino acids of Mtb chorismate mutase at its N terminus, and the
remainder is alkaline phosphatase lacking its native signal sequence.
Using similar methods, we constructed plasmid pCDF4, expressing
from the arabinose-inducible promoter a ssPhoA with a 16-aa N-
terminal extension not expected to function as a signal sequence. An
E. coli strain designated MGPH1, bearing a deletion of the gene for
alkaline phosphatase, was constructed in two steps using bacteriophage
P1-mediated transduction. Plasmids pCDF3 and pCDF4 were trans-
formed into MGPH1. E. coli PhoA is known to be active only after export
to the periplasmic space (31). Hence, blue-colored transformants on LB
plates supplemented with the PhoA chromogenic substrate XP (40
g/ml) and the inducer L-arabinose (0.2%) were expected only if the
putativeMtb chorismate mutase 1 signal sequence mediated the export
of the appended PhoA variant to the periplasm.
RESULTS
The Hypothetical ORF Rv1885c of Mtb Encodes a Functional
Chorismate Mutase Enzyme—The gene corresponding to the
ORF Rv1885c ofMtbwas PCR-amplified, cloned, and expressed
in E. coli BL21 cells, and recombinant protein was purified to
near homogeneity (Fig. 2A). The kinetic properties of the puri-
fied protein were studied using chorismate mutase activity
assays. The substrate saturation curves were hyperbolic for the
enzyme, i.e. the enzyme followed Michaelis-Menten kinetics.
There was no indication of positive homotropic cooperativity of
Mtb chorismate mutase toward chorismate. Km for the enzyme
was calculated as 1.2 mM, and Vmax was calculated as 74 mol
min1 mg1 (Fig. 2B). The molar catalytic activity (kcat) was 26
s1. The effects of temperature and pH on enzyme kinetics
were also studied. Because spontaneous arrangement of cho-
rismate to prephenate is strongly dependent on temperature,
blanks of the same reaction without the enzyme were also kept
at different temperatures, and the readings were subtracted
from those obtained in the presence of the enzyme.Mtb choris-
mate mutase was found to be maximally active in the temper-
ature range of 37 °C to 50 °C. An increase in temperature did
increase enzyme activity (as expected), and complete denatur-
ation of the enzyme occurred at a temperature close to 60 °C.
TABLE I
Bacterial strains and plasmids
Strains/plasmids Description Source/ref.
E. coli strains
BL21 DE3 F  ompT hsdSB (rB mB) gal lon dcm (DE3) Studier and Moffatt (54)
DH5 (argF-lac)U169 supE33 hsdR17 recA1 endA1 gyrA96 thi-1 relA1(80 lacZ
M15)
Hanahan (53)
AD494 F lac pro lacIq  (ara- leu)7697 araD 139 (lac) X74 galE galK rpsLphoR
(phoA) PvuII (malF)3 thi trxB::kan
Derman et al. (41)
GJ1902 zbh-900::Tn10dKan(Ts)1 lacZ::Tn10dKan proC259 Dr. J. Gowrishankar, lab stock
MG1655 Wild-type E. coli K-12
MGPH1 MG1655  phoA lacZ:: Tn10dKan This work
Plasmids
pET23a Expression vector Novagen
pETCM1 pET23a derivative with Mtb CM1 (Rv1885c) cloned in NdeI/XhoI sites This work
pETCM2 pET23a derivative with Mtb CM2 (Rv0948c) cloned in NdeI/XhoI sites This work
pGEMTEasy Cloning vector Promega
pCDF1 pGEMT Easy derivative with ss-less E. coli phoA cloned in vector MCS This work
pCDF2 pET23aCM1 derivative with ss-less E. coli phoA cloned in SalI/XhoI sites
downstream of Mtb CM1 signal sequence
This work
pBAD 18 Expression vector Guzman et al. (30)
pCDF3 pBAD18 derivative with the putative Mtb CM1 signal sequence appended
E. coli phoA cloned in XbaI/HindIII sites
This work
pCDF4 pBAD18 derivative with ss-less E. coli phoA containing a 16-aa N-terminal
extension cloned in XbaI/HindIII sites
This work
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The pH value also has a significant role in determining the
activity of chorismate mutase. Mtb chorismate mutase was
found to be active between pH 6 and pH 8.5, with a pH opti-
mum of 7.5. The pH optimum is similar to that of E. coli
chorismate mutase, for which maximum activity is at pH 7.3.
Chorismate mutase activity of rRv1885 was greatly inhibited
at acidic pH. Whereas fungal chorismate mutases are reported
to be more active at acidic pH, bacterial chorismate mutases
(E. coli P protein and Salmonella typhimurium CM) are re-
ported to be active at alkaline pH (14, 32). Bacillus chorismate
mutase has maximum activity in the range of pH 5 to pH 9 (33).
Hence, the pH range at which Mtb chorismate mutase works
efficiently is similar to that of B. subtilis, with the optimum pH
being closer to that of E. coli chorismate mutase.
Mtb Chorismate Mutase (Rv1885c) Does Not Display Pre-
phenate Dehydratase (PDT) or Prephenate Dehydrogenase
(PDH) Activity—Although PDT or PDH domains have not been
predicted to be present in the ORF Rv1885c, on account of
several examples of divergent evolution of enzymes involved in
aromatic amino acid biosynthesis (12), we decided to test
whether Mtb chorismate mutase displays PDT or PDH activi-
ties. PDT and PDH assays were accordingly carried out with
the recombinant protein. Our results show that the PDT/PDH
activity of rRv1885c is only 0.01% of its CM activity, which
suggests that the protein does not possess any intrinsic PDT or
PDH activity (data not shown). This is unlike the chorismate
mutases of many other enteric bacteria, in which chorismate
mutase and PDT/PDH are present as fusion proteins (14).
Mtb Chorismate Mutase (Rv1885c) Shows Allosteric Regula-
tion by Tyrosine, Phenylalanine, and Tryptophan—Having
shown that the hypothetical protein coded by ORF Rv1885c
encodes a functionally active chorismate mutase enzyme with
no associated PDT or PDH activity, we tested L-phenylalanine,
L-tyrosine, and L-tryptophan as potential modifiers of the cho-
rismate mutase activity of rRv1885c. A very unusual property
of the enzyme could be seen. Whereas these ligands moderately
enhance chorismate mutase activity at low concentrations,
they inhibit the enzyme at higher concentrations. The Eadie-
Scatchard plots of the three ligands show a noncompetitive-
type enzyme inhibition (Fig. 3). It is interesting to note that all
known forms of chorismate mutase that show allosteric regu-
lation are usually large fusion proteins (14), whereas the Mtb
chorismate mutase is a small protein of 22 kDa. The monofunc-
tional chorismate mutase of B. subtilis is entirely resistant to
feedback inhibition by aromatic amino acids (33). E. coli cho-
rismate mutase exists as a fusion protein and shows allosteric
inhibition only by pathway-specific inhibitors (14). Allosteric
regulation of Mtb chorismate mutase is also unlike that of
yeast chorismate mutase, in which tryptophan causes only
activation, whereas tyrosine and phenylalanine cause inhibi-
tion of enzyme activity (34).
Fluorometric assays were carried out to determine whether
phenylalanine binding causes a conformational change in Mtb
chorismate mutase. A blue shift in the spectra and the quench-
ing of net fluorescence indicate that tryptophan residues of the
enzyme are buried inside as a consequence of phenylalanine
binding (Fig. 4). Mtb chorismate mutase possesses four trypto-
phan residues, and therefore the quenching phenomenon is
expected to be primarily due to a change in the conformation of
the protein upon ligand binding (35). Fluorescence quenching is
also a reflection of an alteration in the function of the enzyme.
This could be seen in the inhibition of enzyme activity in the
presence of aromatic amino acids.
Pathway-specific and Cross-pathway-specific Ligands Pro-
tect Mtb Chorismate Mutase from Proteolytic Cleavage—Hav-
ing demonstrated that tyrosine, phenylalanine, and trypto-
phan are allosteric inhibitors of Mtb chorismate mutase
activity, we proceeded to determine whether binding of these
ligands causes a conformational change in the enzyme that
leads to inaccessibility of the active site. We employed limited
proteolysis as a structural probe to ascertain enzyme confor-
mational change. Trypsin was taken as the protease of choice,
and limited proteolysis was carried out to study the amenabil-
ity of the enzyme to proteolytic cleavage in the presence of
various ligands. We observed that in the presence of high
concentrations (3 mM) of effectors (Tyr, Phe, and Trp), the
enzyme was completely protected from proteolytic degradation
(Fig. 5, AC). Salicylic acid, another cross-pathway secondary
metabolite derived from chorismate, did not confer any protec-
tion on the enzyme (Fig. 5D).
Mtb Chorismate Mutase Is a Dimeric Protein with a Predom-
inantly -Helical Structure—Whereas catalytic activity and
regulatory activity of Mtb chorismate mutase point toward
some novel properties of the enzyme, the study was continued
to determine the biophysical parameters of the enzyme to de-
fine the actual class to which it belongs. Size exclusion chro-
matography was performed to determine the oligomeric state of
the protein. The output was a single peak corresponding to the
dimeric state of the recombinant protein (data not shown). In this
context,Mtb chorismate mutase is similar to the E. coli or yeast
chorismate mutases, which are also dimers of identical subunits
(24, 36). To determine the secondary structure ofMtb chorismate
mutase, the CD spectrum was recorded on a JASON spectropo-
larimeter (Fig. 6). The data were analyzed using the K2D soft-
ware available on-line. The results suggest a predominantly
-helical structure for the enzyme. This is reminiscent of the
AroQ class of enzymes from yeast andE. coli (24, 37) that are also
helical proteins. Members of the AroQ class of chorismate muta-
ses consist of unregulated and regulated (AroQr) enzymes and
are unusually divergent among closely related organisms (38).
This structure showed 71% helices with essentially no -sheets.
FIG. 2. Mtb chorismate mutase encoded by ORF Rv1885c fol-
lows Michaelis-Menten kinetics. A, purification of the chorismate
mutase enzyme (Rv1885c) of Mtb as a recombinant protein in E. coli.
The ORF corresponding to Rv1885c was cloned in the NdeI and XhoI
sites of pET23a vector with a C-terminal His tag and expressed in
E. coli BL21 cells. Affinity purification of recombinant protein was
carried out using Talon resin (Clontech). The purified protein was
resolved on 10% Tris-tricine gel, and the gel was stained with Coomas-
sie Brilliant Blue dye. M represents the protein molecular size marker
(Broad range, Genei, India). E1E7 show the successive eluted frac-
tions of the recombinant protein. Arrowhead indicates the position of
the 22-kDa protein, which is the predicted mass of Mtb chorismate
mutase. B, the purified recombinant protein corresponding to ORF
Rv1885c was assayed for chorismate mutase activity in the absence of
any effector molecule. The data were fitted to functions describing
Michaelis-Menten-type saturation to calculate Km and Vmax.
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The N-terminal Signal Sequence of Mtb Chorismate Mutase
Can Mediate the Export of Signal Sequence-less E. coli Alkaline
Phosphatase to the Periplasmic Space—Whereas our experi-
mental evidence in support of a dimeric -helical structure for
Mtb chorismate mutase classified the enzyme as an AroQ-class
chorismate mutase, the prediction of a signal peptide in the N
terminus of the protein further led us to determine whether
Mtb chorismate mutase belongs to the periplasmic subclass of
chorismate mutases. The predicted signal sequence showed a
high similarity score to that of Gram-positive as well as Gram-
negative bacterial signal sequences. The chorismate mutases of
E. herbicola, Pseudomonas aeruginosa, and S. typhimurium
also possess an N-terminal signal sequence and differ in this
respect from other members of the AroQ class of chorismate
mutases (39). A study was therefore initiated to assess the
function of the N-terminal signal sequence (ss) of Mtb choris-
mate mutase in the heterologous host E. coli. Our approach
involved tagging the putative Mtb chorismate mutase signal
sequence to the E. coli alkaline phosphatase (PhoA) lacking its
native signal sequence. The recombinant DNA molecule encod-
ing such a fusion was cloned in pBAD18 vector (30), wherein its
expression is driven from an arabinose-inducible promoter. The
resultant construct pCDF3 was used to transform an E. coli
strain lacking PhoA. PhoA is known to be inactive in the
cytosolic space and active only after export into the periplasm
(31). On the other hand, PhoA lacking its ss is retained in the
cytoplasm, does not possess export competence, and is inactive
(40–42). PhoA activity results in the ability to cleave the cog-
nate chromogenic substrate XP, leading to the appearance of
blue-colored colonies. We observed that pCDF3 transformants
of the E. coli strain lacking endogenous PhoA activity gave rise
to blue-colored colonies, whereas those bearing vector alone
remained white, on LB plates supplemented with L-arabinose
and XP (Fig. 7A). In addition, transformants of MGPH1 ex-
pressing from arapBAD promoter a ss-less version of PhoA
with a 16-aa N-terminal tag encoded by plasmid pCDF4 gave
rise to white colonies on XP indicator plates. The said 16-aa
extension is not expected to encode a ss. Consequently, the
PhoA activity was localized to the cytoplasm, in which it is
inactive. We confirmed that the PhoA activity expressed from
pCDF4was cytoplasmic because it could be reactivated in strains
lacking thioredoxin reductase activity (data not shown), a diag-
nostic feature of cytoplasmically retained PhoA (41). This indi-
cated that only the putative Mtb chorismate mutase signal se-
quence could mediate the export of a heterologous protein to the
periplasmic space. In an independent approach, we also assessed
localization of chorismate mutase in the periplasmic and cyto-
plasmic fractions of E. coli BL21DE3 cells expressing rRv1885c
and rRv2386c. Rv2386c is an ORF ofMtb that does not possess a
predicted signal sequence at its N terminus. A very large propor-
tion of the chorismate mutase activity was confined to the
periplasmic space in cells expressing rRv1885c, whereas the pro-
tein product of Rv2386c partitioned exclusively in the cyto-
plasm (Fig. 7B). From these genetic and biochemical studies it
could be concluded that the Rv1885c-encoded chorismate mu-
tase is a periplasmic protein, at least in a heterologous host.
Rv1885c Is Not the Sole Chorismate Mutase Enzyme of Mtb:
Rv0948c Also Shows Chorismate Mutase Activity, Although
with a Reduced Turnover—The Cluster of Orthologous groups
FIG. 3. Eadie-Scatchard plots show-
ing allosteric regulation of Mtb CM
(Rv1885c) by aromatic amino acids.
The CM activty of Rv1885c was tested in
the presence of various allosteric effectors
(tyrosine, phenylalanine, and trypto-
phan). Low concentrations (up to 100 M)
of all three aromatic amino acids led to a
modest increase in enzyme activity. How-
ever, at higher concentrations of the effec-
tors (500 M), CM activity was greatly
inhibited.
FIG. 4. Phenylalanine binding leads to a change in the fluo-
rescence spectrum ofMtb CM. Fluorescence emission spectra were
recorded by exciting the protein at 280 nm and recording the emission
spectra in the range of 305–440 nm. A blue shift was observed upon
incubation of rRv1885c with phenylalanine, indicating that the tryp-
tophan residues are buried inside as a consequence of phenylalanine
binding.
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annotation of the Mtb genome suggests that chorismate mu-
tase activity could be attributed to two ORFs ofMtb, Rv1885c
and Rv0948c. Hence, we cloned and expressed Rv0948 as well
in E. coli and assayed the recombinant protein for chorismate
mutase activity. It could be seen that even rRv0948 has a
chorismate mutase activity, although its molar catalytic ac-
tivity is 60-fold lower than that of Rv1885c (Fig. 8). The Km
and Vmax of rRv0948 were determined as 5 mM and 1.2 mol
min1 mg1, respectively. Km and Vmax of Rv0948 are unal-
tered even when assayed in the presence of an unrelated
protein, IdeR. This is a reliable indication of the in vitro
specificity of Rv0948 toward chorismate and supports our
view that Rv0948 codes for a CM enzyme, although its activ-
ity is modest.
The existence of another chorismate mutase in the Mtb ge-
nome is consistent with the hypothesis that a free monofunc-
tional chorismate mutase never exists in a single copy in any
genome (43). However, it is inconsistent with the hypothesis
that among two copies of chorismate mutases, at least one is a
fusion protein. rRv0948 also showed no PDT or PDH activity,
indicating that it is also a monofunctional protein (data not
shown). Rv0948 was also found to be resistant to proteolytic
digestion in the presence of phenylalanine and tryptophan
(data not shown).
DISCUSSION
Chorismate mutase is known to be the sole example of an
enzyme that catalyzes a pericyclic rearrangement reaction and
has therefore drawn extensive attention from biologists and
FIG. 6. CD spectrum of Mtb chorismate mutase (Rv1885c) sug-
gests a predominantly -helical secondary structure of the pro-
tein. The graph has been plotted as ellipticity (in millidegrees (m deg))
as a function of wavelength (in nm). The percentage of helicity for
secondary structure determination was calculated using the K2D soft-
ware available on-line (www.embl-heidelberg.de/andrade/k2d/). The
spectrum confirms a highly helical structure of the recombinant protein
with signature peaks at 208 and 222 nm.
FIG. 7. The N terminus of Mtb chorismate mutase (Rv1885c)
encodes a functional signal sequence. A, E. coli strain MGPH1
lacking endogenous PhoA was transformed with plasmids pBAD18,
pCDF3, and pCDF4. The transformants were streaked on LB plates
supplemented with 40 g/ml XP, 0.2% L-arabinose, and the appropriate
antibiotic. Alkaline phosphatase activity is observed only in cells ex-
pressing Mtb CM1 ss-tagged version of PhoA from plasmid pCDF3 (a).
Cells transformed with plasmids pBAD18 (b) and pCDF4 (c) remain
white. B, Western blot demonstrating the presence of Mtb chorismate
mutase in the periplasmic space of E. coli. 5 mg of protein from the
cytosolic (C) and the periplasmic (P) fractions of E. coli BL21 (DE3) cells
expressing the His6 tagged ORFs Rv2386c and Rv1885c were trans-
ferred to nitrocellulose membrane and probed with monoclonal anti-
histidine antibodies. Rv2386c is used as a control protein that does not
possess an N-terminal signal sequence. As evident onlyMtb chorismate
mutase, product of the ORF Rv1885c shows a periplasmic location.
FIG. 5. Aromatic amino acids at
high concentrations provide protec-
tion to Mtb chorismate mutase from
trypsin cleavage as evident from lim-
ited proteolysis studies. Mtb choris-
mate mutase enzyme (Rv1885c) is pro-
tected from tryptic cleavage in the
presence of high concentrations of tyro-
sine, phenylalanine, and tryptophan (3
mM). Salicylic acid, another cross-path-
way effector molecule, did not protectMtb
CM (Rv1885c) from proteolytic cleavage.
M represents the protein molecular size
marker.
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chemists. Earlier reports that have referred to differences in
the structure and regulatory properties of the enzyme from
different sources led us to initiate the study of the respective
properties of the equivalent protein from Mtb. Our approach
involved a detailed biochemical and biophysical characteriza-
tion of recombinant Mtb chorismate mutase, encoded by ORF
Rv1885, and comparison of these properties with enzymes from
other sources. Our results conclusively place Mtb chorismate
mutase, coded by ORF Rv1885c, in the AroQ class of periplas-
mic chorismate mutases.
In the course of this study, we also came across several
unique properties of Mtb chorismate mutase that are impor-
tant in the context of differentiating the enzyme from the
bacterial and fungal counterparts. The first and foremost ob-
servation with respect to the regulation of Mtb chorismate
mutase by aromatic amino acids revealed an unusual property
of the enzyme. Whereas Mtb chorismate mutase was found to
be allosterically regulated by pathway-specific (Tyr and Phe) as
well as cross-pathway-specific (Trp) ligands in the same man-
ner, it showed a modest increase in enzyme activity at low
concentrations and complete inhibition at higher concentra-
tions of effectors. Whereas it is difficult to explain the observa-
tion, our results suggest that the activity of Mtb CM is a
reflection of a complex interplay between ligand concentration
and enzyme activity. We also propose that this unusual prop-
erty of Mtb chorismate mutase must be coordinately regulated
with other enzymes of the aromatic amino acid pathway. It
would be worthwhile to mention that a recent study from our
laboratory indicates that Mtb PheA (prephenate dehydratase),
the enzyme that catalyzes the subsequent step in the biosyn-
thesis of phenylalanine, is regulated in exactly the opposite
manner, i.e. it is inhibited by low concentrations and activated
by higher concentrations of aromatic amino acids (44). This
suggests in that in Mtb sequential enzymes of the aromatic
amino acid biosynthesis pathway are regulated in an opposite
manner to bring about a balance of intracellular concentrations
of these amino acids.
Because binding of ligands causes inhibition of enzyme ac-
tivity, we investigated whether ligand binding would also pro-
tect the enzyme from proteolytic cleavage. This experiment was
expected to generate another line of evidence that ligand bind-
ing induces a conformational change in the enzyme. Limited
proteolysis studies suggest that ligand binding imparts a much
more rigid structure to the enzyme, leading to enhanced sta-
bility and inaccessibility of the active site and protease cleaving
sites. A cross-pathway-specific secondary metabolite, salicylic
acid, could not protectMtb chorismate mutase from proteolytic
cleavage. Salicylic acid is also derived from chorismate. This
suggests that only aromatic amino acids and not secondary
metabolites have a binding pocket on the enzyme.
The chorismate mutase reaction is also known to occur spon-
taneously, and we also observed an increase in conversion of
chorismate to prephenate at higher temperatures. However,
there was a distinct enhancement of the reaction rate upon
addition of the enzyme. We believe that despite a spontaneous
conversion of chorismate to prephenate, there is a need for
enzyme-catalyzed conversion because chorismate is a substrate
for multiple enzymes, and the fate of the compound is deter-
mined by the enzyme that acts upon it, which in turn is de-
pendent on the requirement of the organism (45).
It is also interesting to note that unlike most enteric bacte-
ria, in which chorismate mutase exists in fusion with other
enzymes of the aromatic amino acid biosynthesis pathway,
Mtb chorismate mutase is predicted to be a non-fusion protein
(www.sanger.ac.uk/cgi-bin/Pfam/speciesview.pl?family
CM_2&accPF01817&ncbicode83332&nameMycobacterium
%20tuberculosis). However, because of several reports of diver-
gent evolution of aromatic amino acid biosynthesis enzymes,
we tested whether the amino acid sequence of Mtb chorismate
mutase could also contribute to PDT or PDH activity. Our
results confirm that Mtb chorismate mutase is a monofunc-
tional protein, i.e. it has no associated PDT or PDH activity.
The chorismate mutases that show allosteric regulation are
usually large fusion proteins. Mtb chorismate mutase appears
to be unique in the sense that despite being a small monofunc-
tional protein, it shows a complex pattern of allosteric regula-
tion. Whereas Mtb chorismate mutase does not possess a dis-
crete ACT domain that is required for amino acid binding, it is
possible that the complex regulatory activity of the enzyme
rests in the uncharacterized C terminus of the enzyme.
Among the monofunctional AroQ proteins, the existence of a
cleavable signal peptide has been reported in E. herbicola.
Later, AroQ chorismate mutases from S. typhimurium and
P. aeruginosa were also shown to have a periplasmic location
(46). Periplasmic chorismate mutases possess a signal peptide
at the N terminus and usually have a C terminus of an un-
known function. The C terminus of Mtb chorismate mutase is
also unique, and its precise function is still unclear. Based upon
its ability to export E. coli PhoA to the periplasmic space, we
tentatively place Mtb chorismate mutase in the unique
periplasmic subclass of AroQ proteins. However, our study also
necessitates a requirement for identification of other periplas-
mic enzymes of the aromatic amino acid biosynthesis pathway
ofMtb. This study would shed further light on whether there is
a periplasmic pathway of aromatic amino acid biosynthesis in
Mtb. In the absence of the existence of such a pathway, we
propose that the periplasmic location of Mtb chorismate mu-
tase could have a role to play in modulation of the host immune
response or that the enzyme could have a chemotactic role (47).
It is interesting to note that the ORF Rv1885c exists in the
same operon as Antigen85A, a major secreted antigen ofMtb. It
is also worth mentioning that chorismate mutase is a virulence
factor of nematode parasites that secrete chorismate mutase
from their esophageal glands to alter the shikimate pathway of
the plants that they parasitize (48, 49).
Finally, our evidence for the existence of another chorismate
mutase in theMtb genome is in accordance with the hypothesis
that a free monofunctional chorismate mutase never exists in a
single copy in any genome (43). Interestingly, however, this is
the first report that demonstrates the existence of two mono-
functional chorismate mutases in any bacterial system. In
other bacteria, in which chorismate mutase is present in two
copies, at least one of them is a fusion protein (50). Evolution of
these fusion proteins was brought about with the purpose of
coordination of gene expression as per the requirement of the
cell. Hence, the issue of co-regulation of Mtb chorismate mu-
FIG. 8.Comparative study of the chorismatemutase activity of
the ORFs Rv1885c and Rv0948c. Purified fractions of both the pro-
teins were used for CM activity assay. V versus [S] plot of rRv1885c and
rRv0948c. As evident from the graph, Rv0948c also possesses CM
activity; however, the specific activity of rRv0948c was 60-fold lower
than the specific activity of Rv1885c.
Chorismate Mutase of M. tuberculosis 19647
 by guest, on O
ctober 11, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
tases and PDT/PDH still remains. Whereas IdeR is known to
govern the expression of Mtb prephenate dehydratase (51),
regulation of expression of Mtb chorismate mutase is still not
known. The apparent lack of synchrony in gene expression also
suggests thatMtb chorismate mutase could be involved in some
other pathway that is independent of the involvement of
PDT/PDH.
Our data support the existence of two monofunctional cho-
rismate mutases in theMtb genome, yet the question remains:
why two chorismate mutases? The clue lies in our observation
of a huge difference in turnover number of the two chorismate
mutases, which suggests that one of these enzymes could have
an additional function. Additionally, the existence of one of the
chorismate mutases as a secreted protein also suggests an as
yet undeciphered function of the enzyme. The second choris-
mate mutase of Mtb (Rv0948) does not possess a signal se-
quence, which suggests that there are possibly two pathways
for aromatic amino acid biosynthesis in Mtb. The role of the
periplasmic pathway is still not clear. Our other novel obser-
vation that the periplasmic chorismate mutase of Mtb shows a
higher turnover number also demands elucidation of some
other function of the enzyme. Because chorismate-utilizing en-
zymes are known to have divergently evolved, it is likely that
these enzymes could have some other function as well. In this
context, it would be important to mention that in P. aeruginosa,
the isochorismate pyruvate lyase enzyme PchB has been re-
ported to show chorismate mutase activity (52). We are cur-
rently exploring whether either of the chorismate mutase en-
zymes could substitute for an isochorismate pyruvate
lyase enzyme.
In summary, our results show that the hypothetical proteins
coded by the ORFs Rv1885c and Rv0948c of M. tuberculosis
represent the chorismate mutase enzymes of the organism and
that the kinetic properties of the enzyme are under the control
of strict regulatory mechanisms. To our knowledge, this is the
first detailed report that provides evidence for the existence of
a monofunctional AroQ class of periplasmic chorismate mutase
in the Mtb genome. Additionally, a low level sequence similar-
ity of the protein with other known chorismate mutases makes
this protein an attractive molecule for the design of novel
therapeutic compounds for intervention against tuberculosis.
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